Skip to main content
See every side of every news story
Published loading...Updated

Blood Test Could Predict when Alzheimer’s Symptoms Will Begin

Researchers at Washington University created models using plasma p-tau217 levels to predict Alzheimer's symptom onset within 3-4 years, aiding early intervention and trials.

  • On Feb. 19, researchers at Washington University School of Medicine in St. Louis developed a single blood test measuring plasma p‑tau217 that estimates Alzheimer’s symptom onset within about three to four years.
  • Because amyloid and tau accumulate years before symptoms, the team aimed to enable earlier prediction so patients considering preventive care can access treatment and clinical trial designers can speed trials.
  • Using data from 3 older adults, the researchers measured plasma p‑tau217 on PrecivityAD2 and other FDA‑cleared tests, sharing their clock models as public code and a web app.
  • Petersen said `These clock models could make clinical trials more efficient by identifying individuals who are likely to develop symptoms within a certain period of time`, but tests are not recommended for people without symptoms outside research or trials.
  • In contrast, the research intersects with funding and care costs, affecting over 7 million Americans and nearly $400 billion in 2025, with symptom onset about 20 years after age 60 p‑tau217 rise and 11 years after age 80.
Insights by Ground AI

11 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 43% of the sources are Center
43% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Time News broke the news in on Monday, February 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal